Gadzhieva Z.K.
Gazimiev M.A.
Kazilov Y.B. Yu B
Grigoryan V.A.
I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia, Moscow, Russia.
Hospital of the MIA of the RF for the Republic of Dagestan, Makhachkala, Russia.
The combined symptoms of male lower urinary tract: current treatment options
Текст визуальный электронный
Urologiia (Moscow, Russia : 1999)
№ 4 С. 135-141
2018
-blocker
anticholinergic
lower urinary tract symptoms
solifenacin
storage symptoms
tamsulosin
vezomni
voiding symptoms
Статья
Обзор
Drug Therapy, Combination E02.319.310
Лекарственная терапия комбинированная E02.319.310
Humans B01.050.150.900.649.313.988.400.112.400.400
Человек B01.050.150.900.649.313.988.400.112.400.400
Lower Urinary Tract Symptoms C23.888.942.343
Lower Urinary Tract Symptoms therapy C23.888.942.343
Мочевых путей нижних симптомы C23.888.942.343
Мочевых путей нижних симптомы терапия C23.888.942.343
Male
Мужской
Prostatic Hyperplasia C12.100.500.565.500 C12.200.294.565.500
Предстательной железы гиперплазия C12.100.500.565.500 C12.200.294.565.500
Solifenacin Succinate D03.605.687.900 D03.633.100.531.820.594
Солифенацина сукцинат D03.605.687.900 D03.633.100.531.820.594
Sulfonamides D02.065.884 D02.886.590.700
Сульфонамиды D02.065.884 D02.886.590.700
Treatment Outcome E01.789.800 N04.761.559.590.800 N05.715.360.575.575.800
Лечения результатов анализ E01.789.800 N04.761.559.590.800 N05.715.360.575.575.800
Urinary Bladder A05.810.890
Мочевой пузырь A05.810.890
Journal Article V02.600
Журнальная статья V02.600
Review V02.600.500 V02.912
Обзор V02.600.500 V02.912
This literature review presents current data on epidemiology and views on the pathogenesis of male lower urinary tract symptoms. The authors discuss current options for the management of male lower urinary tract symptoms using a fixed-dose combination drug that includes one of the most selective and safe 1-blockers tamsulosin OCAS and the most selective of anticholinergic agent solifenacin.